Vivos Therapeutics, Inc.Vivos Therapeutics, Inc.Vivos Therapeutics, Inc.

Vivos Therapeutics, Inc.

No trades
See on Supercharts

Price target

6.300.000.00%
The 2 analysts offering 1 year price forecasts for VVOS have a max estimate of — and a min estimate of —.

Analyst rating

Based on 2 analysts giving stock ratings to VVOS in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


VVOS EPS for the last quarter is −0.40 USD despite the estimation of −0.66 USD. In the next quarter EPS is expected to reach −0.40 USD. Track more of Vivos Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Vivos Therapeutics, Inc. revenue is expected to reach ‪3.89 M‬ USD. Check out Vivos Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, VVOS price target is 6.30 USD with a max estimate of 6.60 USD and a min estimate of 6.00 USD. Check if this forecast comes true in a year, meanwhile watch Vivos Therapeutics, Inc. stock price chart and keep track of the current situation with VVOS news and stock market news.